Dr. Robert Doll, MD (he/him) is an Endocrinologist in Allentown, PA with over 17 years of experience. What is your opinion of Dr. Robert Doll, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Robert Doll, MD has received over $81,970 which includes payments from the following companies:
$73,324.90 from Novo Nordisk Inc
$3,658.83 from Shire North American Group Inc
$1,009.67 from LILLY USA, LLC
$936.08 from AstraZeneca Pharmaceuticals LP
$459.39 from Janssen Pharmaceuticals, Inc
$336.55 from Boehringer Ingelheim Pharmaceuticals, Inc.
$293.25 from GlaxoSmithKline, LLC.
$245.45 from Medtronic MiniMed, Inc.
$205.76 from Dexcom, Inc.
$182.23 from sanofi-aventis U.S. LLC
$171.47 from AbbVie, Inc.
$170.95 from Merck Sharp & Dohme Corporation
$151.44 from Aegerion Pharmaceuticals, Inc.
$150.26 from INSULET CORPORATION
$114.75 from Roche Diabetes Care, Inc.
$84.13 from Takeda Pharmaceuticals America, Inc.
$77.56 from Tandem Diabetes Care, Inc.
$69.31 from Amgen Inc.
$55.68 from Abbott Laboratories
$47.22 from Novartis Pharmaceuticals Corporation
Payments received by Dr. Robert Doll, MD were from the following categories:
$67,628.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!